The largest database of trusted experimental protocols

Sirnagdf11

Manufactured by GenePharma
Sourced in China

The SiRNAGDF11 is a laboratory equipment product from GenePharma. It is designed for the in vitro delivery of small interfering RNA (siRNA) targeting the GDF11 gene. The core function of this product is to facilitate the transfection of siRNA into cells to modulate the expression of the GDF11 gene.

Automatically generated - may contain errors

2 protocols using sirnagdf11

1

Knockdown of GDF11 in Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Small interfering RNA (siRNA) specific for GDF11 gene expression (siRNAGDF11) and control scrambled siRNA were synthesized by GenePharma Co., Ltd (Shanghai, China). Cells were seeded at 1x105 per cell into 12‐well plates one day before transfection. Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) (2 μL/mL) was mixed with siRNAs (final 50 nmol/L) in reduced serum medium OptiMEM (Invitrogen) and then added into each well (1ml per well). Medium was changed to DMEM containing 10% FBS 8 hours after transfection and cultured for further analysis. Expression of GDF11 at levels of mRNA and protein was detected by RT‐PCR and Western blot, respectively. For the experiment of differentiation that lasted 14 days, the cells were transfected with siRNA again 7 days after the first transfection to maintain GDF11 being knocked down. VEGF165 was added to the culture 24 hours after either transfection to induce differentiation of MSCs to ECs.
+ Open protocol
+ Expand
2

Silencing GDF11 Gene Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Small interfering RNA (siRNA) specific for GDF11 gene expression (siRNAGDF11) and control scrambled siRNA were synthesized by GenePharma Co., Ltd (Shanghai, China). Cells were seeded at 1 × 105 cells per well into 12-well plates one day before transfection. The siRNAs (final 50 nM) were mixed with Lipofectamine 2000 (Invitrogen, USA) (2 μl/ml) in medium OptiMEM (Invitrogen, USA) and then added into each well (1 ml per well). Medium was changed into DMEM containing 10% FBS 8 h after transfection and cultured for further analysis. Expression of GDF11 at levels of mRNA and protein was detected by RT-PCR and Western blot, respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!